Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 4519796, 5 pages
https://doi.org/10.1155/2017/4519796
Research Article

Follow-Up (Measurement) of Corrected QT Interval in Adult Patients before and after Lung Transplantation

1University of Giessen and Marburg Lung Center (UGMLC), The German Center for Lung Research (DZL), Klinikstrasse 33, 35392 Giessen, Germany
2Klinikum Westmünsterland, St. Agnes-Hospital Bocholt Rhede, Medical Clinic 1-Cardiology/Electrophysiology, Barloer Weg 125, 46397 Bocholt, Germany
3Department of General and Thoracic Surgery, University Hospital of Giessen, Rudolf-Buchheim-Strasse 7, 35392 Giessen, Germany
4Klinikum Lüdenscheid, Universität Witten-Herdecke, Medizinische Klinik III, Paulmannhöherstr. 14, 58515 Lüdenscheid, Germany
5Department of Thoracic Surgery, Kerckhoff Heart and Lung Center, Benekestrasse 2-8, 61231 Bad Nauheim, Germany
6Department of Intensive Care Medicine, Kerckhoff Heart and Lung Center, Benekestrasse 2-8, 61231 Bad Nauheim, Germany
7Medical Clinic 1, University Hospital Giessen and Marburg GmbH, Klinikstrasse 33, 35392 Giessen, Germany

Correspondence should be addressed to Dirk Bandorski

Received 5 May 2017; Revised 3 October 2017; Accepted 17 October 2017; Published 6 November 2017

Academic Editor: Paul M. Tulkens

Copyright © 2017 Dirk Bandorski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. Alvarez and J. Pahissa, “QT alterations in psychopharmacology: proven candidates and suspects,” Current Drug Safety, vol. 5, no. 1, pp. 97–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. B. J. Drew, M. J. Ackerman, M. Funk et al., “Prevention of torsade de pointes in hospital settings: A scientific statement from the American heart association and the American college of cardiology foundation,” Circulation, vol. 121, no. 8, pp. 1047–1060, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. D. M. Roden, “Drug-induced prolongation of the QT interval,” The New England Journal of Medicine, vol. 350, no. 10, pp. 1013–1022, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Simkó, A. Csilek, J. Karászi, and I. Lorincz, “Proarrhythmic potential of antimicrobial agents,” Infection, vol. 36, no. 3, pp. 194–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. R. L. Woosley and K. A. Romero, QT drugs List, accessed -11-23, AZCERT, Inc. 1822 Innovation Park Dr, AZ 857552016, Oro Valley, rizona, 2016, http://www.Crediblemeds.org.
  6. P. J. Schwartz and R. L. Woosley, “Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes,” J Am Coll Cardiol, vol. 67, pp. 1639–1650, 2016. View at Google Scholar
  7. G. Sarganas, E. Garbe, A. Klimpel, R. C. Hering, E. Bronder, and W. Haverkamp, “Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany,” Europace, vol. 16, no. 1, pp. 101–108, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. C. Johnson, S. So, J. W. Marsh, and A. M. Murphy, “QT prolongation and torsades de pointes after administration of FK506,” Transplantation, vol. 53, no. 4, pp. 929-930, 1992. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Mohamed, P. R. Forsey, M. K. Davies, and J. M. Neuberger, “Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease,” Hepatology, vol. 23, no. 5, pp. 1128–1134, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. A. O. Zurick III, B. J. Spier, T. C. Teelin et al., “Alterations in corrected QT interval following liver transplant in patients with end-stage liver disease,” Clinical Cardiology, vol. 33, no. 11, pp. 672–677, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Zamirian, M. Tavassoli, and K. Aghasadeghi, “Corrected QT interval and QT dispersion in cirrhotic patients before and after liver transplantation,” Archives of Iranian Medicine, vol. 15, no. 6, pp. 375–377, 2012. View at Google Scholar · View at Scopus
  12. W. P. Miller, R. Shanley, and P. Dorostkar, “Cardiac QTc interval characteristics before and after hematopoietic stem cell transplantation: An analysis of 995 consecutive patients at a single center,” Bone Marrow Transplantation, vol. 50, no. 7, pp. 954–960, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Monfared, Z. A. Roshan, A. Salari et al., “QT intervals in patients receiving a renal transplant,” Experimental and Clinical Transplantation, vol. 10, no. 2, pp. 105–109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Ikitimur, K. Cosansu, B. Karadag et al., “Long-term impact of different immunosuppressive drugs on QT and PR intervals in renal transplant patients,” Annals of Noninvasive Electrocardiology, vol. 20, no. 5, pp. 426–432, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Goldman, Principles of Clinical Electrocardiography, Appleton and Lange, Los Altos, CA, USA, 12 edition, 1986.
  16. L. Schamroth, An introduction to electrocardiography, Blackwell Scientific, Oxford, 7 edition, 1990.
  17. H. C. Bazett, “The time relations of the blood‐pressure changes after excision of the adrenal glands, with some observations on blood volume changes,” The Journal of Physiology, vol. 53, no. 5, pp. 320–339, 1920. View at Publisher · View at Google Scholar · View at Scopus
  18. L. S. Fridericia, Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken, vol. 53 of The duration of systole in the electrocardiogram of normal subjects and of patients with heart disease, Acta Medica Scandinavica, 1920.
  19. M. Hodges, D. Salerno, and D. Erlien, “Bazett's QT correction reviewed: evidence that a linear QT correction for heart rate is better,” Journal of the American College of Cardiology, p. 694, 1983. View at Google Scholar
  20. A. Sagie, M. G. Larson, R. J. Goldberg, J. R. Bengtson, and D. Levy, “An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study),” American Journal of Cardiology, vol. 70, no. 7, pp. 797–801, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. P. M. Rautaharju, B. Surawicz, and L. S. Gettes, “AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the american heart association electrocardiography and arrhythmias committee, council on clinical cardiology; the american college of cardiology foundation; and the heart rhythm society. endorsed by the international society for computerized electrocardiology,” Journal of the American College of Cardiology, vol. 53, no. 11, pp. 982–991, 2009. View at Publisher · View at Google Scholar
  22. D. Babuty, M. Aupart, P. Cosnay et al., “Electrocardiographic and electrophysiologic properties of cardiac allografts,” Journal of Cardiovascular Electrophysiology, vol. 5, no. 12, pp. 1053–1063, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Luo, K. Michler, P. Johnston, and P. W. MacFarlane, “A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs,” Journal of Electrocardiology, vol. 37, pp. 81–90, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Chiladakis, A. Kalogeropoulos, P. Arvanitis, N. Koutsogiannis, F. Zagli, and D. Alexopoulos, “Preferred QT correction formula for the assessment of drug-induced QT interval prolongation,” Journal of Cardiovascular Electrophysiology, vol. 21, no. 8, pp. 905–913, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Vandenberk, E. Vandael, T. Robyns et al., “Which QT correction formulae to use for QT monitoring?” Journal of the American Heart Association, vol. 5, no. 6, Article ID e003264, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. D. S. Peal, R. W. Mills, S. N. Lynch et al., “Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen,” Circulation, vol. 123, no. 1, pp. 23–30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. M. Brostoff and D. N. Lockwood, “Glucocorticoids as a novel approach to the treatment of disabling side effects of sodium stibogluconate,” Journal of Clinical Pharmacy and Therapeutics, vol. 37, no. 1, pp. 122-123, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. C. Sanguinetti, C. Jiang, M. E. Curran, and M. T. Keating, “A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel,” Cell, vol. 81, no. 2, pp. 299–307, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. M. C. Trudeau, J. W. Warmke, B. Ganetzky, and G. A. Robertson, “HERG, a human inward rectifier in the voltage-gated potassium channel family,” Science, vol. 269, no. 5220, pp. 92–95, 1995. View at Publisher · View at Google Scholar · View at Scopus